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T his study analyzed in vivo antiviral cellular immune reac-
tions in the Shope rabbit papilloma - carcinoma model. Anti-
gens studied in experimentally infected domestic rabbits 
were cottontail rabbit papillomavirus particles produced with 
the athymic (1114 \ 1114) mouse xenograft system and bacterial 
fusion proteins containing the major or minor capsid protein. 
Recall reactions to antigens were tested by class ic intracuta-
neous tests. Positive reactions had a biphasic course . Histopa-
thology of skin test biopsy specimens showed infiltrating 
poly morph onuclear cells during the earl y stages. Later they 
were replaced by predominantly perivascular infiltrates com-
posed of mononucl ear cells. Time course of swelling and 
infiltrates resembled a delayed-type hypersensitivity reac-
B enign and malignant diseases caused by human papil-lomaviruses (HPV) represent a serious public health threat. Development of a vaccination strategy there-fore has emerged as one of the main goals of papillo-mavirus (PV) research [1]. Therapeutic vaccination for 
pre- existing lesions, however, requires know ledge of the cellular 
immune response that is thou ght to mediate regression of warts 
[2,3]. Most immunologic research in the PV field has focused on 
humoral immune responses [4] because technical difficulties have 
hampered studies of the cell-mediated immune response to HPV. A 
key role ofT cell s in controlling PV-induced lesions is suggested by 
mononuclear cell infi ltrates observed in warts durin g regression [5] . 
Furth ermore, an association of skin and cervical cancers with certain 
class I [6] and cl ass II [7,8] histocompatibili ty complexes exists and 
T -ce ll determinants on HPV proteins have been demonstrated 
[9, 10] . However, the reported lymphoproliferative responses to PV 
antigens measured itl vitro are weak [11 ,12]. 
In vitro assays probabl y reflect onl y in part the complex interac-
tion between virus and host. In contras t, the administration of anti-
gens intracutaneously allows investigation of the subsequent im-
mune reaction ill situ in the exact same tissue w here infection with 
PV occurs. Although the first application of intracutaneous skin 
rests for PV anti gens was published in 1977 [13], the then recog-
nized oncogenic potential of some HPV types [1 4] did not allow 
furth er use of skin tests in humans. Molecular biologic techniques 
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tion. T en of 11 regressor rabbits (p = 0.00006) and 10 of 20 
progressors (p = 0.009) had positive skin tests with intact 
and/ or denaturated virus particles and individual capsid pro-
teins also could elicit specific skin reactions. Skin reactivity to 
the cottontail rabbit papillomavirus particles was also greater 
\P = 0.042) in regressor rabbits (8 of 11) when compared to 
progressors (7 of 20) . Reca ll reactions remained detectable at 
post-regress ion times, ranging from several months up to 
more than 2 years. W e conclude that specific skin reactions 
against the cottontail rabbit papillomavirus in infected do-
mestic ra~bits e~ist, a n~ are. strongly positive to intact parti-
cles of tl1lS papIlloma VIruS 111 animals (regressors) clinica lly 
free of disease.] In llest Dermatoll0l :227 -231 , 1993 
made.possible both the production of saf~ components of even high-
risk viruses and the re1l1troductlOn of tlus test for PV research . Re-
cently we have used the major capsid protein L1 of HPV 16 for skin 
tests in patients with cervical intraepithelial neoplasia and observed 
a ~elayed-type hypersensiti.vi ty (DTH) reaction against L1 [1 5]. 
Sbn tests With oncogemc vtrlons, however, are restricted to use in 
animal models. 
The purpose of this study was to determine whether cellular 
immune responses against cottontail rabbit papillomavirus (CRPV) 
could be detected by sk1l1 tes ts 111 the Shope papilloma - carcinoma 
complex (SPCC) of rabbits [1 6, 17]. In the SPCC model, rabbits 
challenged with C RPV develop papillomas at all inoculated sites 
after 2 to 3 weeks, and rapid growth occurred during the next 1 to 2 
months. In 10 - 40% of rabbits, spontaneous regression of all papil-
lomas occurs after 1 to 3 months, and of the remaining rabbits with 
pe.rsistent papillomas (d~fined as progr.essors), 40 - 60% develop 
pnmary epidermOid carcl110mas at the site of the papilloma 1 to 2 
yea~s after inoculation [1 ~] . The SPC.C model displays striking sim-
dan ty to HPV-1I1duced diseases and IS one of the few useful animal 
models for PV infections. The existence of specific skin reactions 
against C RPV particl es and genomic products in deliberately in-
fected domestic rabbits should be determined. 
MATERIALS AND METHODS 
Animals N ew Zealand w hite rabbits were purchased from H azel ton Re-
search Animals, Denver, PA. Rabbits were inoculated w ith a 10- 2 dilution of 
C RPV (prepared fro m wild cottontail papilloma extracts [18]) at fom sites. 
Regressor rabbits consisted of 11 animals with spontaneous and complete 
disappearance of papillomas. Regressor status was confirmed by res istance to 
reinfec tion with C RPV DNA. Progressor rabbits consisted of 20 an imals 
with pers istin~ papillomas. Six anima ls included in the progressor group had 
cancer at the tllne of testing. Nine ull infec ted animals served as naive con-
tro ls. 
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Vir us Stocks and Test Antigens 
Vir ions: CRPV and HPV 11 virions were prepared from cysts developed in 
the athymic 1111/ '111 mouse xenograft system as previously described [1 9]. PV 
particles were purified on CsCI step gradients. Disrupted virus was prepared 
by incubation of identical aliquots of the virion preparation in carbonate 
buffer (0.2 M Na2CO" 0.01 M dithiothreitol (pH 10.6)) for 30 mill at room 
temperature and then 5 min at 95 ' C. Both virus preparations were further 
purified with centricon 10 fi lters (Amlcon, Beverly, MA). Protem content 
was measured at 170 Ilg/ml (Bio Rad protein assay, Richmond, CAl. Intact 
virus preparations were analyzed by enzyme-linked immunosorbent assay 
(ELISA) with monoclonal antibodies (CRPV-IA, HI1.B2) known to react 
only with intact CRPV or HPV II particles, respectively [20] . VIral particle 
disruption was confi rmed with ant isera against the PV group ~pecific anti gen 
(Dako, Carpinteria, CAl recogntzmg only denaturated anttgens. Altquots 
were stored in 70% glycerol/ phosphate-buffe red saline at -20 'C. 
FIISio ll Proteill s: The CRPV open reading frames for the major (Ll) and 
minor capsid proteins (L2) were cloned into CJX vectors and expressed in 
Escherichia coli as ell fusion proteins [21] . T he proteins were purified by 
sodium dodecyl su lfa te-polyacrylamide gel electrophoresis, electroel uted, 
and then analyzed by ELISA and Western blotting. Protein solutions (200 
.ug/ml) were aliquoted and stored at - 20'C. Control proteins of the same 
size and concentration were identica lly prepared from extracts of bacteria 
containing the CJX vector without viral insert. 
Immunization 
Keyhole lim pet iJ emocYallill : (Calbiochem, Behring, La Jolla CAl was pre-
pared as 1 mg/ml stock solution in phosphate-buffered sa line. Keyhole 
limpet hemocyanin (200 .ug) emulsified with complete Freund's adjuvant 
was injected subcutaneously once into eight rabbits either 3 to 6 weeks or at 
least 1 year before DTH tests. 
Skin Test T he procedure, modified as previously described [22] consisted 
of the intracutaneous injection of 0.03 ml (5 .ug antigen) test solution into 
the ear skin. Pilot studies were conducted to optimize the concentrations and 
volumes of anti gen preparations. Contro l preparations were injected into the 
contralateral ea r. Collars were fi tted to all rabbits to prevent non-specific 
inflammation caused by scratching. Antigenic interference [23] was avoided 
by testin g the fusion proteins at least 2 weeks after testing the virus prepara-
tions. Ear swell ing was monitored over 5 d and measured to th e nearest 0.01 
mm with a constant tension th ickness gauge. In addition, the intensi ty and 
diameter of erythema was documented with scored arbi trary va lues of 0, +, 
++ as fo llows: lesions < 3 mm were designated as 0; distinct reactions> 3 
mm, which r~mained visible at least 5 d werejudged as +; erythema> 5 mm 
and palpable swellings were documented as ++. Retesting of some animals 
(nine regressors, two progressors, six naive rabbits) was performed apptoxi-
mately 6 months afte r the first series of tests. 
Tissue Preparation and Staining Procedure Biopsies at days 1- 6 afte r 
injection of antigen were taken from repeated skin tests. They were divided 
in to two parts, and either fi xed in 10% neutral-buffered formalin or embed-
ded in OCT compound (Miles, Elkhart , IN) and snap-frozen in liquid nitro-
gen. Frozen tissue blocks were stored at - 70 'C until use. Formalin-fixed 
tissues were used for routine hematoxylin and eosin staining. Immunohisto-
chemistry on frozen tissue was performed with the monoclonal antibody 
Lll /135 (anti - pan-T lymphocytes) as described previously [5] . 
Statistical Analyses Significance levels were detcrmined at the upper 
95% confidence limit of the average ear swelling 48 h aftcr idcntical antigcn 
injection into control animals. Ear swellings thicker than the mean swelling 
in naive rabbi ts + 2 X SD,, _ I (and judged with arbitrary erythema values + 
or ++) were considercd as positivc. Statistical analyscs were perfo rmed using 
th e Mann-Whi tney U tcst and the Fisher exact probabi lity tcst. 
RESULTS 
Cha racteristics of the Skin Test Reaction W ithin m inutes 
afte r inocul ation o f anti gen into rabbit ears, skin- to bright red-co-
lored w heals appeared . In naive rabbits, the average skin sw elling 
decreased consta ntly and w as again cl ose to the pre- injectio n thick-
ness after 72 h. Ind uratio n persisted approximately 7 CI in positive 
reac tio ns (Fi g 1) . Antige n ti tratio n fo r animals w ith strong anti gen-
T HE JO URNA L OF INVESTIGAT IVE DERMATO LOGY 
0 .8r--'--~-~-~-~"" 
E 0.8 . \ 
~ . t 0 .4 .\~ 
~ '" .-~ ~ 0.2 ~- "'--... _-... ____ • ____ 
~: 
O.OL---_~ _ _'.,_ _ ___"_-== _ _i'l-' 
o 24 48 72 96 120 
hours after Ag injection 
Figure 1. Recall reactions in regressor rabbi t R 106 afte r intracutaneous 
injcction of 0.03 ml of CRPV particlcs into the ear skin. Critical dependence 
of swelling on the concentration of antigen solutions:., 170 .ug!ml; A, 17 
.ug/ml; e, 1.7 .ug/ml; average swellin g in nine naivc rabbits given 170 
.ug/ml (0) . Bars, SEM. 
specific reactio ns sho w ed discernible responses to 1 : 100 dilution of 
antigen (0.05 fl g protein) . The kinetics o f the skin test reaction 
against de natura ted antige ns was different than th at against C RPV 
particles, because in regressor and progressor rabbits swellin g to the 
latter antigen increased between 48 and 72 h . In regressors, the 
average sw elling to denatured C RPV decreased linearly, but was 
still greater at all time po ints than the sw elling obtained from naive 
animals challenged w ith C RPV antigen (Fi g 2A ). T ime course of 
sw elling was m o re obvious when no n-specific background reactiv-
ity o f contro l animals w as subtracted (Fig 2B) . In th e later phase of 
positive reactions, typically fl at reddish papul es developed, w hich 
rem ained clearly visible fo r up to 2 w eeks. 
Histopathology Histopatho logic chan ges over time were exam-
ined microscopicall y from punch biopsies as described in Materials 
and Methods (data no t shown) . Earl y stages revealed sli ght edem a of 
the dermis and mixed Iympho histiocytic infiltrates with predomi-
nantly polym orphonucl ear cell s. Analogues o f neutrophils in 
humans appear as pseudoeosino ph ils in rabbits [24]. Som e fibrinoid 
necrosis o f vessels was p rese nt. Later biopsy specimens show ed a 
perivascular dermal infiltratio n and the cell infiltrate w as m ore 
m o no nuclear in nature w ith large blas tlike lymphocytes , occasional 
h istiocytes, and som e po lym orpho nucl ear cells. Infiltrating cells 
0 .6 0 .6 
A B I I 0.5 0 .5 I E ~ E ,5 0.4 ,5 0.4 OJ OJ ~ "'~--+~ :§ 0 .3 [ 0.3 Qi ., ~ r: zi'" ~ t, · . ......... ' U) U) 0.2 " , T ! , ro 0 .2 r/~ r ~1 ro . ("J ., i~T " + ., 0. 1 0.1 
· 1----. -~----~ 1 ____ ! 0 .0 0 .0 
a 24 48 7 2 96 120 0 24 . 48 72 96 120 
hours a ft er Ag injec ti on hours aft er Ag injection 
Figure 2. A, T imc coursc of swelling to CRPV particles versus dcnaturated 
CRPV protcins after intracutaneous injection of 5 .ug antigcn: Average ear 
swelling to CRPV particles in all 11 regressor rabbits tested (e) and in nine 
naive rabbits (0 ); reaction to disrupted CRPV particles in fi ve regressor 
rabbi ts positive with this solution (.) and in ninc naive rabbits (0). B, results 
shown in A after substraction of non-specific background swelling to corre-
sponding antigen in naive rabbits : rcgressor rcac tivity to CRPV particles (e) 
and to disrupted CRPV particles (.) . Bars, SEM. 
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Table I. Summary of Skin T ests with Cottontail Rabbit Papillomavirus Anti gensn 
Regressors 
Progressors 
Naives 
In tact CRPV 
8/11 
7/20 
0/9 
Disrupted CRPV 
5/10 
7/20 
0/9 
Combincdb 
10/ 11 
10/20 
0/9 
L 1' 
2/8 
5/13 
0/ 7 
2/ 8 
5/12 
1/8 
Combined' 
3/8 
7/ 13 
1/8 
'" Positive skin tests (measured 48 h after antigen inoculat ion) per number of animals tested. 
• Rabbits positive to challenge with either/or both intact or disrupted CRPV antigen. 
' Fusion protein of CRPV Ll. 
, Fusion protein of CRPV L2. 
, Rabbits positi ve to challenge with either or both fusion proteins L1 and L2. 
were predominantl y labeled w ith th e pan T-cell marker L11 \ 135 
(data not show n). In some cases, necrosis was observed in the deep 
dermis of coll agen bundles . 
s kin Test Results in Regressor, Progressor, and Naive 
R abbits Skin tes t reactions were measured 48 h after anti gen 
innocul ation for groups of regressor, progressor, and naive rabbits 
and the data are summarized in T able 1. T en of 11 regressor rabbits 
had positi ve skin tes t reactions to one or both virus preparations, 
wh ic h was hi ghly significa nt w hen compared to naive rabbits (p = 
0.00006). Eight of 11 reactions to C RPV particles were positive' 
(p = 0.001 3). M ean swelling of positive reactions in regressor rab-
bi ts was 0.29 mm. The three reactions judged nega tive at 48 h were 
on ly sli ghtl y below the 95% confidence limit and increased be-
tween 48 and 72 h, a feature th at never occurred in naive rabbits. 
Five of 1 0 regressors reacted aga inst th e denatured virus preparation 
(p = 0.021) and the mean swelling of these positive reactions was 
0.26 mm. Response in regressor rabbits to the fusion proteins was 
not s tatistica lly significa nt. 
In progressor rabbits, only 10 of20 skin tes ts were positive with 
intact or disrupted C RPV. Seven of 20 progressors reacted with 
CRPV particl es (mea n swelling, 0.26 mm) or with the denaturated 
viru s preparation (mea n swelling , 0 .28 mm) respectively (when 
com p ared with naive rabbits, p = 0.05) . The only significant posi-
tivity w ith fu sion proteins compared with naive rabbits was seen 
with L1 in w hich 5 of 13 progressors were positive (p = 0.049). 
There was no statistically differen t response for any anti gen prepa-
ra t io n between the 14 rabbits w ith papillomas and the 6 rabbits with 
cancer (data not shown) . 
M ean swelling in naive rabbits to C RPV particl es was 0.102 mm 
(SD n - 1 = 0.036) and to disrupted C RPV 0.068 mm (SO,,_ I = 
0.05 5). There was only one positive skin test reaction to any C RPV 
antigens in naive rabbits and that was a reaction to the L2 fu sion 
pro te in . When regressor rabbits were compared with progressor 
rabbits, a difference in reactivity was seen (Fig 3). In contras t to 
progressor rabbits, skin reactivity in regressor rabbits was preferen-
tia ll y directed against intact C RPV particles. Consequently, reac-
tivity to intact C RPV particl es, but not to denatured anti gens, was 
grea ter in regressors when compared with progressors (p = 0.042). 
The Mann-Whitney U test, applied to analyze the abso lute mea-
sured data, confirmed this significance. The difference was even 
more evident w hen time course da ta for the skin test reaction was 
com pared (Fig 4) . There were no regressor rabbits with background 
swe lling only . Conversely, 13 of 20 progressors reacted nearly 
identicall y to naive rabbits. 
Results observed in regressor rabbit skin tes ted 6 months after the 
init ia l OTH tests demonstrated long-lasting and reproducible reac-
tivity. Two of th ese animals were tested 2 years after papilloma 
regression . Retested naive rabbits remained negative such that no 
measurable se nsitization during th e initial tes tings had occurred. 
Control Antigens N o skin reactivity was observed in any of the 
rabbits w ith the HPV 11 contain ing preparations. In contrast, there 
was so me tendency in progressor, regressor, and naive rabbits alike 
for reactivity to the corresponding control preparations for the fu-
sion proteins. In all these cases, equiva lent responses to the corre-
sponding fusion protein Ll or L2 were judged as negative. 
Recall reactions to KLH in all eight previously immunized re-
gressor and progressor rabbits ali ke were strong (++) and ranged 
between 0.48 and 1.55 111m after 48 h. T he strongest reaction in the 
three rabbits sensitized approxi mately 1 year before tes ting was 0.75 
mm. In five previously unchallenged animals, average swelling was 
0.14 mm (SO,, _ I = 0.04) . 
DISCUSSION 
In this study, we examined ski n tes t reactivity in C RPV-in fec ted 
domestic rabbits. The specificity of the reaction to C RPV antigen 
was demonstrated , because no responses to control anti gens were 
observed when in fec ted and uninfected rabbits were compared. Fur-
thermore, there was, WIth one exception, no reactivity to C RPV 
anti gens in naive rabbits, w hich indicated that immunolog ic mem-
ory was required for the reac tion. 
The time course ~f swellin g and leukocyte infiltration in positive 
tests was charac tenstlc for a type IV hyperse nsitivity, or OT H , 
reactio~ ~s. described by Coom~s and Gell [25). D elayed-type hy-
persensItivIty reactIons 111 rabbIts have been previously described 
with tuberculin purified protein derivative in immunized ani-
mals. As observed in our rabbi ts with CRPV anti gens, local accu-
mulation of po lymorphonuclear cells inducing pl asma extra vasa-
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Figure 3. Ear swelling to intact and disrupted CRPV particles in regressors 
versus progressor rabbits: reactivity in regressors but not in progressors was 
preferentially directed against intac t virions. L ilIes connect paired reactions 
from individual rabbits to both antigens. Horizoll lal bars, the upper 95% 
confidence limits of the reac tivity of naive rabbits to these antigen prepara-
tions. 
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Figure 4. Ea r skin swelling to intrac uta neously injected CRPV particles . 
Prog rcsso r rabbits separated into two subgroLlps: Seven skin test p ositive (_) 
a nd 13 skin test negative progressors (0). All regressors ex hibit swelling 
above bac kground: e ight skin t est positi ve regressors (e) and three reg resso r 
rabbits judged skin test n egative 48 h afte r antigen injectio n (0 ); background 
swelli ng in nine naive rabbits (t.) . Bars, SEM. 
tion wi th a maximum at 24 h followed by lymphocyte-dependent 
t issue swelling was described [26]. Biopsy specimens of positive skin 
lesions in the later phase of the reaction contained perivascular 
lymphocytic infiltrates as seen in type IV hypersensitivity [27] . Sim-
il ar infiltrates have been observed in spontaneously regressing warts 
[5,28] and in PV skin tests in patients with CIN [15]. 
Capsid proteins elicited specific skin test reactions, but additional 
antigens could have also served as targets for the observed response. 
Although the administered dose was subinfectious, the CRPV par-
ticles used for testing have to be regarded as principally infective. 
Early post-infection events could have taken place at the skin test 
site. Consequently, as suggested by i/1 vitro studies [29] , early CRPV 
ge nomic products, and possibly additional virus-induced cellular 
proteins may also have been presented to th e T cells. Reduced or lost 
infecti vity o f disrupted C RPV offers one explanation why individ-
ual rabbits did not respond identically to intact and disrupted CRPV 
particles. 
Responses of regressor and progressor rabbits to C RPV antigens 
showed a tendency for progressor rabbits to have stronger reactivity 
to denatured ant igens, and less reactivity to intact antige ns than 
regressors. We have observed that progressor rabbits have increased 
antibody responses to denatured C RPV proteins than do regressors 
and this may be due to increased antigen shedding from the persist-
ing papillomas of th e progressors . Interestingly, antibody titers to 
intac t CRPV antigens as measured by ELISA were similar in both 
progressors and regressors (data not shown). 
T hat DTH against CRPV was observed is intriguing because 
co ntact immunotherapy for treatment of resistant common warts is 
very effective [30] . However, to date, skin tests in patients are rou-
tinely used for granulomatous infectious diseases but not for viral 
infections [31]. Recently, virus-specific DTH [32] and cytotoxic 
T-ce ll react ivity [33] have bee n assessed in skin tests using animal 
models for other viruses . The presented study of skin tes ts in the 
Shope model co nfirms its usefulness in eva luation ofT-cell immu-
noreactivity to PV irl vivo and encourages extended application of 
skin tests for PV resea rch. 
In summary, reactivity against CRPY particles was long lasting 
and greater in regressor th an in progressor rabbits. However, this 
association does not provide sufficient evidence for a causative rol e 
of this reaction in papilloma regression. That some regressors had 
skin test reactivity to C RPY particl es and sensitiza tion to C RPV 
antigens, as a consequence of previously induced regression, cannot 
be excluded. W e co nclude that DTH reactivity exists in CRPV-in-
fected rabbits. Applica tion of skin tests in th e Shope animal model is 
a sensitive tool to study T-cell mediated immunity to Py and can be 
used in furt her studies with other C RPY proteins, sLlch as the early 
proteins known to be present in PY lesions and ca ncer. 
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